🕵️ Akebia Therapeutics, Inc. ($AKBA)
SEC insider & ownership activity, last 12 months · CIK 1517022 · every row links its SEC filing
Over the last 12 months insiders sold $963K against $87K of open-market buying. John P. Butler sold $474K through a 10b5-1 trading plan in 4 lots (Feb–Mar). Blackrock, Inc. added 6.1% → 7.2%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $87K (1 lots) · 6 sellers, $963K (16 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| John P. Butler | 1 | $87K | 4 | $474K | Mar 4, 2026 |
| Grund Nicholas | 0 | – | 2 | $118K | Feb 2, 2026 |
| Ostrowski Erik | 0 | – | 2 | $111K | Jun 29, 2026 |
| Carolyn M. Rucci | 0 | – | 3 | $97K | Feb 2, 2026 |
| Burke Steven Keith | 0 | – | 3 | $94K | Feb 2, 2026 |
| Richard C. Malabre | 0 | – | 2 | $69K | Feb 2, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 7.2% | 13G | Jan 21, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Ostrowski Erik | $62K | Jun 29, 2026 | filing ↗ |
| Ostrowski Erik | $49K | Feb 2, 2026 | filing ↗ |
| Grund Nicholas | $118K | Feb 2, 2026 | filing ↗ |
| Burke Steven Keith | $94K | Feb 2, 2026 | filing ↗ |
| John P. Butler | $476K | Feb 2, 2026 | filing ↗ |
| Carolyn M. Rucci | $97K | Feb 2, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Jun 30, 2026 | filing ↗ |
| Other events (8.01) | Jun 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 30, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 17, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 27, 2026 | filing ↗ |
| Earnings (2.02) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 27, 2026 | filing ↗ |
| New financial obligation (2.03) | Jan 27, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 27, 2026 | filing ↗ |
| Earnings (2.02) | Jan 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Material agreement (1.01) | Nov 28, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 28, 2025 | filing ↗ |
| Other events (8.01) | Nov 28, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 28, 2025 | filing ↗ |
| Material agreement (1.01) | Nov 12, 2025 | filing ↗ |
| Earnings (2.02) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 28, 2025 | filing ↗ |
| Other events (8.01) | Oct 28, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 28, 2025 | filing ↗ |
| Earnings (2.02) | Aug 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2025 | filing ↗ |